Bellerophon Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2015 to Q4 2022

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Bellerophon Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q4 2022.
  • Bellerophon Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2022 was 265 %, a 50.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 265 -269 -50.4% Dec 31, 2022
Q3 2022 353 -160 -31.2% Sep 30, 2022
Q2 2022 437 -91.2 -17.3% Jun 30, 2022
Q1 2022 505 -91.4 -15.3% Mar 31, 2022
Q4 2021 534 +8.3 +1.58% Dec 31, 2021
Q3 2021 513 +63.9 +14.2% Sep 30, 2021
Q2 2021 529 +194 +58% Jun 30, 2021
Q1 2021 596 +415 +229% Mar 31, 2021
Q4 2020 525 +303 +136% Dec 31, 2020
Q3 2020 449 +202 +81.5% Sep 30, 2020
Q2 2020 335 +74.9 +28.9% Jun 30, 2020
Q1 2020 181 -93.8 -34.1% Mar 31, 2020
Q4 2019 223 -81.5 -26.8% Dec 31, 2019
Q3 2019 247 -115 -31.7% Sep 30, 2019
Q2 2019 260 -188 -42% Jun 30, 2019
Q1 2019 275 -200 -42.2% Mar 31, 2019
Q4 2018 304 -170 -35.8% Dec 31, 2018
Q3 2018 362 -85.5 -19.1% Sep 30, 2018
Q2 2018 448 +64.1 +16.7% Jun 30, 2018
Q1 2018 475 +111 +30.3% Mar 31, 2018
Q4 2017 474 +128 +37.1% Dec 31, 2017
Q3 2017 448 +112 +33.3% Sep 30, 2017
Q2 2017 384 -6.27 -1.61% Jun 30, 2017
Q1 2017 365 -90.7 -19.9% Mar 31, 2017
Q4 2016 345 -173 -33.3% Dec 31, 2016
Q3 2016 336 -150 -30.8% Sep 30, 2016
Q2 2016 390 Jun 30, 2016
Q1 2016 455 Mar 31, 2016
Q4 2015 518 Dec 31, 2015
Q3 2015 486 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.